Free Trial
FRA:SRT3

Sartorius Aktiengesellschaft (SRT3) Stock Price, News & Analysis

Sartorius Aktiengesellschaft logo
€234.30 +7.20 (+3.17%)
As of 05/2/2025

About Sartorius Aktiengesellschaft Stock (FRA:SRT3)

Key Stats

Today's Range
€227.80
€235.50
50-Day Range
€175.85
€247.50
52-Week Range
€71.00
€124.70
Volume
91,633 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Receive SRT3 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SRT3 Stock News Headlines

Sartorius Aktie: Weg der Besserung!
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the quiet buildup behind the scenes. Now, in just days, the floodgates are set to open. The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent — and four tiny miners could be your ticket to 100X gains.
Here's what to expect from Sartorius's earnings
Sartorius Aktiengesellschaft (SRT3.VI)
See More Headlines

SRT3 Stock Analysis - Frequently Asked Questions

Sartorius Aktiengesellschaft's stock was trading at €217.80 at the beginning of 2025. Since then, SRT3 shares have increased by 7.6% and is now trading at €234.30.
View the best growth stocks for 2025 here
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sartorius Aktiengesellschaft investors own include NVIDIA (NVDA), Alliance Data Systems (ADS), Bayer Aktiengesellschaft (BAYN), Tesla (TSLA), Texas Instruments (TXN), Abbott Laboratories (ABT) and Accenture (ACN).

Industry, Sector and Symbol

Stock Exchange
FRA
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
FRA:SRT3
CIK
N/A
Fax
N/A
Employees
14,143
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (FRA:SRT3) was last updated on 5/3/2025 by MarketBeat.com Staff
From Our Partners